Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mRNA vaccines in the prevention and treatment of diseases

25 Aug 2022

Abstract excerpt

Messenger ribonucleic acid (mRNA) vaccines made their successful public debut in the effort against the COVID-19 outbreak starting in late 2019, although the history of mRNA vaccines can be traced back decades. This review provides an overview to discuss the historical course and present situation of mRNA vaccine development in addition to some basic concepts that underly mRNA vaccines. We discuss the general...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36033422
DOI: 10.1002/mco2.167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mRNA vaccines in the prevention and treatment of diseasesPMID 36033422Read ↗

Development of mRNA Vaccines/Therapeutics and Their Delivery SystemSemantic proximity Read ↗

mRNA-based modalities for infectious disease managementSemantic proximity Read ↗

Current Developments and Challenges of mRNA VaccinesSemantic proximity Read ↗

The Delivery of mRNA Vaccines for TherapeuticsSemantic proximity Read ↗

Progress and challenges of mRNA vaccinesSemantic proximity Read ↗

mRNA Vaccine Technology Beyond COVID-19Semantic proximity Read ↗

Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic VirusesSemantic proximity Read ↗

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read ↗

The Development of mRNA Vaccines for Infectious Diseases: Recent UpdatesSemantic proximity Read ↗

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read ↗

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read ↗

An Update on mRNA-Based Viral VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.